As custodians to ensure patient safety, quality teams in pharma firms must have a mechanism not only to comply but to consistently comply, says Rashida Najmi, Senior Vice President, Global Quality, Regulatory, Pharmacovigilance and Patents, Piramal Enterprises. For this to happen, compliance to quality needs to become part of the culture of a company
Dear friends in the pharmaceutical space. Having spent more than 30 years in pharma quality, through this publication I aim to create a general awareness on quality culture. I fully recognise that the content in this article is based on my views and there can be an alternate or contradictory view which may be equally valid.
Often times in various events and conferences that I attend outside pharma quality, it makes me ponder about the fast pace at which several other high risk industries (like automobile, aerospace, banking etc) have grown leaving pharma to be viewed as a snail in bringing innovation to market. The time to market for any pharma discovery is on an average 12.5 years with the cost of over £1 billion. There is also high degree of molecule attrition as the journey progresses on the drug development life cycle.
Why does pharma take a conservative approach?
There is a reason behind such a conventional approach to drug development and licensing process. The most significant reason is delayed knowledge of its adverse outcome and low possibility of its retraction once consumed. Unlike faulty cars, air planes, etc. which can be possibly recalled, drugs once administered cannot be retrieved back from the patient’s body. Similarly, while risk to human life due to faulty cars and jet planes can be as huge, the risk is known immediately if it crashes. In the case of medicines, the risks could be evident after several years, decades or generations. These are the factors that make pharma researchers and regulators take a conservative approach.
ãã®èšäºã¯ Express Pharma ã® April 16-30, 2019 çã«æ²èŒãããŠããŸãã
7 æ¥éã® Magzter GOLD ç¡æãã©ã€ã¢ã«ãéå§ããŠãäœåãã®å³éžããããã¬ãã¢ã ã¹ããŒãªãŒã9,000 以äžã®éèªãæ°èã«ã¢ã¯ã»ã¹ããŠãã ããã
ãã§ã«è³Œèªè ã§ã ?  ãµã€ã³ã€ã³
ãã®èšäºã¯ Express Pharma ã® April 16-30, 2019 çã«æ²èŒãããŠããŸãã
7 æ¥éã® Magzter GOLD ç¡æãã©ã€ã¢ã«ãéå§ããŠãäœåãã®å³éžããããã¬ãã¢ã ã¹ããŒãªãŒã9,000 以äžã®éèªãæ°èã«ã¢ã¯ã»ã¹ããŠãã ããã
ãã§ã«è³Œèªè ã§ã? ãµã€ã³ã€ã³
Blissfill-Calibrated syringe pipettes for repetitive laboratory dosing as per ISO 8655-9
Blissfill syringe pipettes provide laboratories with an ergonomic, self-refilling solution for repetitive dosing, delivering precise volumes from 0.05ml to 10ml. With ISO 8655-9 compliance and an included calibration certificate, Blissfill ensures accuracy and ease of use for high-demand lab applications
Ensuring pharma compliance with testo data measurement technology
Comprehensive data measurement tools address regulatory demands and secure quality in pharma
Waters launches software for lab-centric business intelligence enabling audit readiness
waters_connect Data Intelligence software provides laboratories with comprehensive business intelligence on their chromatographic data throughout the product development lifecycle, enabling real-time audit readiness and query response, while reducing time spent on audit preparation
Ensuring clean room integrity with Prime Clean Reset High-Speed Doors
Designed with precision to meet the stringent requirements of controlled environments, Prime Clean Reset is the epitome of performance and reliability, ensuring that your clean room operations consistently meet the highest standards of regulatory compliance and product integrity
Optimising efficiency with Remote Laboratory Solutions
LabWare's comprehensive suite of software solutions designed specifically for laboratories offers reliable Remote Laboratory Solutions to help your business thrive in the current climate
Ensuring water quality with the 6000TOCi: The ultimate solution for continuous TOC measurement
The 6000TOCi Sensor is a comprehensive solution that brings together continuous monitoring, rapid response, reliability, and compliance
Enhancing pharmaceutical analysis in critical areas
Dheeraj Handique, Manager GC/GCMS Product Marketing, Shimadzu Analytical (India) highlights the benefits of GCMS-TQ8050 NX with HS-20 NX trap for genotoxic impurities, nitrosamines, and, extractables and leachables
Technical innovations for Annex 1
To meet the stringent EU GMP Annex 1 requirements, Optima presents innovative solutions to improve product and patient safety in pharmaceutical manufacturing. From minimising glove interventions and optimising First Air flow to advanced automation for integrity testing, this article explores how Optima's technologies support compliance in aseptic fill-and-finish processes
JRS Pharma - The Global MCC Manufacturing Network
JRS Pharma is one of the largest manufacturers of MCC across the globe. The know-how is based on more than 25 years of experience in development of own processes
Mack Pharmatech is the first to launch PLC-based environmental chambers in India
Manoj Choudhari, Managing Director, Mack Pharmatech shares insights on his company's pioneering expand globally and enhance regulatory compliance